Jose Luiz Martins do Nascimento
Overview
Explore the profile of Jose Luiz Martins do Nascimento including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
299
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Galue-Parra A, de Moraes L, Hage A, Castro de Sena C, do Nascimento J, da Silva E
Biomed Pharmacother
. 2024 Sep;
179:117360.
PMID: 39232387
Macrophages undergo activation in response to multiple stimuli, including pathogens, growth factors and natural products. The inflammatory response and oxidative stress play critical roles in such macrophage activation. Some natural...
2.
Silva N, Lopes I, Galue-Parra A, Ferreira I, Castro de Sena C, da Silva E, et al.
Pharmaceuticals (Basel)
. 2024 Jul;
17(7).
PMID: 39065724
A glioma is a type of tumor that acts on the Central Nervous System (CNS) in a highly aggressive manner. Gliomas can occasionally be inaccurately diagnosed and treatments have low...
3.
Arrifano G, Augusto-Oliveira M, Lopes-Araujo A, Santos-Sacramento L, Macchi B, do Nascimento J, et al.
Int J Environ Res Public Health
. 2023 Mar;
20(5).
PMID: 36901217
The COVID-19 pandemic affected billions of people worldwide, and exposure to toxic metals has emerged as an important risk factor for COVID-19 severity. Mercury is currently ranked as the third...
4.
Shinkai V, Sampaio I, Dos Santos E, Galue-Parra A, Ferreira D, Baliza D, et al.
Molecules
. 2022 Dec;
27(24).
PMID: 36557983
Gliomas are the most common primary malignant brain tumors in adults, and have a poor prognosis, despite the different types of treatment available. There is growing demand for new therapies...
5.
Pereira J, de Moraes L, Castro de Sena C, do Nascimento J, Rodrigues A, Marques da Silva S, et al.
Pathogens
. 2022 Aug;
11(8).
PMID: 36015045
Chromoblastomycosis (CBM) is a chronic human subcutaneous mycosis caused by various aetiologic agents. CBM does not have an established treatment but may be managed using antifungal agents, surgical removal of...
6.
Oliveira F, Silva N, Hamoy M, Crespo-Lopez M, Ferreira I, da Silva E, et al.
Molecules
. 2022 Jun;
27(11).
PMID: 35684543
Seizures and epilepsy are some of the most common serious neurological disorders, with approximately 80% of patients living in developing/underdeveloped countries. However, about one in three patients do not respond...
7.
Jesus J, Castro de Sena C, Macchi B, do Nascimento J
Neuroimmunomodulation
. 2021 Aug;
29(1):15-20.
PMID: 34350891
Leprosy, also known as Hansen's disease, continues to have a substantial impact on infectious diseases throughout the world. Leprosy is a chronic granulomatous infection caused by Mycobacterium leprae and shows...
8.
de Lima J, da Silva Fonseca L, Xavier L, Macchi B, Cassoli J, da Silva E, et al.
Pathogens
. 2021 Jun;
10(6).
PMID: 34071265
During tuberculosis, uses host macrophage cholesterol as a carbon and energy source. To mimic these conditions, can be cultured in minimal medium (MM) to induce cholesterol consumption in vitro. During...
9.
Crespo-Lopez M, Augusto-Oliveira M, Lopes-Araujo A, Santos-Sacramento L, Yuki Takeda P, Macchi B, et al.
Environ Int
. 2020 Oct;
146:106223.
PMID: 33120229
Mercury is among the ten most dangerous chemicals for public health, and is a priority concern for the 128 signatory countries of the Minamata Convention. Mercury emissions to the atmosphere...
10.
Oliveira F, Rodrigues K, Hamoy M, Sarquis I, Hamoy A, Lopez M, et al.
Pharmaceuticals (Basel)
. 2020 Mar;
13(3).
PMID: 32164340
Epilepsy is a chronic neurological disease characterized by excessive neuronal activity leading to seizure; about 30% of affected patients suffer from the refractory and pharmacoresistant form of the disease. The...